Baidu
map

2021年6月16日全球新冠肺炎疫情及疫苗接种简报:日新增29.3万,新冠疫苗接种鸿沟形成,非洲仅0.6%人口接种

2021-06-16 MedSci整理 MedSci整理

截至北京时间2021年6月16日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17734万例,新增319,319例,达到177,346,43

截至北京时间2021年6月16日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过17734万例,新增319,319例,达到177,346,431例。累计死亡病例383.6万例,达到3,836,269例。新增死亡为7,468例。康复为161,783,194例,重症和危重症病人达到83,722例;全球新冠确诊病例超过100万例的国家达28个,94个国家病例超10万例。昨日报道:2021年6月15日全球新冠肺炎疫情及疫苗接种简报:日新增29.3万,新冠病毒传播速度比全球疫苗分发速度要快,Novavax的新冠疫苗效果极佳

中国接种新冠疫苗突破9亿剂次 覆盖人群居全球首位

据国家卫健委消息,截至2021年6月14日,31个省(自治区、直辖市)和新疆生产建设兵团累计报告接种新冠病毒疫苗90413.4万剂次。

上一日累计报告接种新冠病毒疫苗89277.0万剂次,新增1136.4万剂

世卫组织:全球累计因新冠死亡超380万例

世卫组织网站最新数据显示,截至欧洲中部时间14日18时45分(北京时间15日零时45分),全球确诊病例较前一日增加353660例,达到175686814例;死亡病例增加10362例,达到3803592例。

美国:1.4亿多人已完成疫苗接种

据约翰斯·霍普金斯大学最新发布数据显示,美国累计死亡病例数近60万。过去两周内,美国有亚拉巴马、阿肯色、夏威夷等8个州的新增确诊病例呈上升趋势。

据美国疾病控制与预防中心通报,上述8个州中,除了夏威夷,其他州的民众疫苗接种率只有约43%。拜登政府此前宣布,到今年7月4日让全美70%的成年人口至少接种一剂新冠疫苗,目前这一数字约为64%。

美国疾病控制和预防中心称,截至12日上午,全美已接种新冠疫苗3.08亿剂。超1.7亿人已接种至少一剂新冠疫苗,1.4亿多人已完成疫苗接种。

巴西:2374万人已完成第二剂接种

截至目前,巴西累计确诊病例数位居全球第三,仅次于美国和印度;而累计死亡病例数则居全球第二,排在美国之后。

据巴西媒体统计,截至14日20时,巴西已有逾5574万人接种了新冠疫苗,占该国人口总数的26.32%。其中,2374万人已完成第二剂接种,占该国人口总数的11.21%。

德国:2181.24万人已实现完全接种

当地时间14日,德国疾控机构公布的新增确诊感染新冠病毒人数为549,为该国近八个月来单日新增确诊数首度低于一千例。

据德国“时代在线”实时数据,截至当地时间14日17时许,德国累计确诊372.2万人、死亡90492人。

截至当天,德国已接种6070万剂次疫苗,2181.24万人已实现完全接种。随着德国国内疫情形势向好,围绕“解封”的讨论日益激烈。

法国:26.6%的成年人口已接种两剂疫苗

法国卫生部12日发布的最新数据显示,法国已有超过3000万人接种至少一剂新冠疫苗,接受两剂疫苗接种的人数已达1567万人。法国57.4%的成年人口已接种至少一剂疫苗,26.6%的成年人口已接种两剂疫苗。

韩国:预计截至本周,将有1300万人完成首剂接种

韩国新冠疫苗预防接种推进团团长(疾病管理厅厅长)郑银敬14日表示,预计截至本周,韩国将有1300万人完成首剂接种,随着接种人群增加,疫苗接种效果将进一步凸显。

非洲:只有约0.6%的人口完成接种

非洲疾控中心公布的数据显示,截至10日,已有50个非盟成员国获得约5490万剂新冠疫苗,其中已经接种3590万剂疫苗。

从覆盖面来看,非洲只有约0.6%的人口完成疫苗接种。疫苗接种排名前五的非洲国家是摩洛哥、埃及、尼日利亚、埃塞俄比亚和南非。

全球新冠疫苗接种概况

Country
Cumulative COVID-19 vaccinations doses
World 2.42 billion
Asia 1.40 billion
Upper middle income 1.21 billion
China 904.13 million
High income 851.64 million
Europe 425.42 million
North America 395.79 million
Lower middle income 344.94 million
United States 310.65 million
European Union 300.78 million
India 252.76 million
South America 143.92 million
Brazil 78.91 million
United Kingdom Jun 13, 2021 71.67 million
Germany Jun 13, 2021 60.74 million
England Jun 13, 2021 60.24 million
France Jun 13, 2021 44.30 million
Italy 42.73 million
Africa 42.32 million
Mexico Jun 13, 2021 37.52 million
Turkey 34.78 million
Spain Jun 13, 2021 33.24 million
Russia 32.87 million
Indonesia 32.04 million
Canada 29.47 million
Japan 25.04 million
Poland Jun 13, 2021 24.47 million
Chile Jun 13, 2021 20.44 million
Morocco 16.69 million
Argentina 16.38 million
Saudi Arabia 15.98 million
South Korea 15.83 million
United Arab Emirates 13.85 million
Colombia Jun 13, 2021 13.02 million
Netherlands Jun 13, 2021 11.40 million
Pakistan Jun 13, 2021 10.70 million
Israel 10.63 million
Bangladesh 10.07 million

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1258027, encodeId=0543125802e0c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 17 22:22:34 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974285, encodeId=70819e428555, content=疫苗接种率防疫的关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Jun 17 08:25:40 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974057, encodeId=91479e4057df, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b255520900, createdName=ms7000001644417250, createdTime=Wed Jun 16 11:45:59 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029601, encodeId=108b1029601a3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 16 10:22:34 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974026, encodeId=63d19e4026f6, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/06f7c5da39ab431d951fe3a04f13726f/96f31ac4ff3f4bebb7196c82e8f9845a.jpg, createdBy=2b415520667, createdName=noctis-, createdTime=Wed Jun 16 10:00:22 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973986, encodeId=d4199e398659, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:10:33 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973985, encodeId=715e9e398591, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:09:47 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973978, encodeId=fea19e39789e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e985494754, createdName=ms9000001266443457, createdTime=Wed Jun 16 07:56:47 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1258027, encodeId=0543125802e0c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 17 22:22:34 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974285, encodeId=70819e428555, content=疫苗接种率防疫的关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Jun 17 08:25:40 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974057, encodeId=91479e4057df, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b255520900, createdName=ms7000001644417250, createdTime=Wed Jun 16 11:45:59 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029601, encodeId=108b1029601a3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 16 10:22:34 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974026, encodeId=63d19e4026f6, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/06f7c5da39ab431d951fe3a04f13726f/96f31ac4ff3f4bebb7196c82e8f9845a.jpg, createdBy=2b415520667, createdName=noctis-, createdTime=Wed Jun 16 10:00:22 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973986, encodeId=d4199e398659, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:10:33 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973985, encodeId=715e9e398591, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:09:47 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973978, encodeId=fea19e39789e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e985494754, createdName=ms9000001266443457, createdTime=Wed Jun 16 07:56:47 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-17 yangchou

    疫苗接种率防疫的关键。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1258027, encodeId=0543125802e0c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 17 22:22:34 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974285, encodeId=70819e428555, content=疫苗接种率防疫的关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Jun 17 08:25:40 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974057, encodeId=91479e4057df, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b255520900, createdName=ms7000001644417250, createdTime=Wed Jun 16 11:45:59 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029601, encodeId=108b1029601a3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 16 10:22:34 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974026, encodeId=63d19e4026f6, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/06f7c5da39ab431d951fe3a04f13726f/96f31ac4ff3f4bebb7196c82e8f9845a.jpg, createdBy=2b415520667, createdName=noctis-, createdTime=Wed Jun 16 10:00:22 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973986, encodeId=d4199e398659, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:10:33 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973985, encodeId=715e9e398591, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:09:47 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973978, encodeId=fea19e39789e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e985494754, createdName=ms9000001266443457, createdTime=Wed Jun 16 07:56:47 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 ms7000001644417250

    积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1258027, encodeId=0543125802e0c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 17 22:22:34 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974285, encodeId=70819e428555, content=疫苗接种率防疫的关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Jun 17 08:25:40 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974057, encodeId=91479e4057df, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b255520900, createdName=ms7000001644417250, createdTime=Wed Jun 16 11:45:59 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029601, encodeId=108b1029601a3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 16 10:22:34 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974026, encodeId=63d19e4026f6, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/06f7c5da39ab431d951fe3a04f13726f/96f31ac4ff3f4bebb7196c82e8f9845a.jpg, createdBy=2b415520667, createdName=noctis-, createdTime=Wed Jun 16 10:00:22 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973986, encodeId=d4199e398659, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:10:33 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973985, encodeId=715e9e398591, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:09:47 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973978, encodeId=fea19e39789e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e985494754, createdName=ms9000001266443457, createdTime=Wed Jun 16 07:56:47 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1258027, encodeId=0543125802e0c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 17 22:22:34 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974285, encodeId=70819e428555, content=疫苗接种率防疫的关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Jun 17 08:25:40 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974057, encodeId=91479e4057df, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b255520900, createdName=ms7000001644417250, createdTime=Wed Jun 16 11:45:59 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029601, encodeId=108b1029601a3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 16 10:22:34 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974026, encodeId=63d19e4026f6, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/06f7c5da39ab431d951fe3a04f13726f/96f31ac4ff3f4bebb7196c82e8f9845a.jpg, createdBy=2b415520667, createdName=noctis-, createdTime=Wed Jun 16 10:00:22 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973986, encodeId=d4199e398659, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:10:33 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973985, encodeId=715e9e398591, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:09:47 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973978, encodeId=fea19e39789e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e985494754, createdName=ms9000001266443457, createdTime=Wed Jun 16 07:56:47 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 noctis-

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1258027, encodeId=0543125802e0c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 17 22:22:34 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974285, encodeId=70819e428555, content=疫苗接种率防疫的关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Jun 17 08:25:40 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974057, encodeId=91479e4057df, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b255520900, createdName=ms7000001644417250, createdTime=Wed Jun 16 11:45:59 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029601, encodeId=108b1029601a3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 16 10:22:34 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974026, encodeId=63d19e4026f6, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/06f7c5da39ab431d951fe3a04f13726f/96f31ac4ff3f4bebb7196c82e8f9845a.jpg, createdBy=2b415520667, createdName=noctis-, createdTime=Wed Jun 16 10:00:22 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973986, encodeId=d4199e398659, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:10:33 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973985, encodeId=715e9e398591, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:09:47 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973978, encodeId=fea19e39789e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e985494754, createdName=ms9000001266443457, createdTime=Wed Jun 16 07:56:47 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 ms3000000367260972

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1258027, encodeId=0543125802e0c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 17 22:22:34 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974285, encodeId=70819e428555, content=疫苗接种率防疫的关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Jun 17 08:25:40 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974057, encodeId=91479e4057df, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b255520900, createdName=ms7000001644417250, createdTime=Wed Jun 16 11:45:59 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029601, encodeId=108b1029601a3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 16 10:22:34 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974026, encodeId=63d19e4026f6, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/06f7c5da39ab431d951fe3a04f13726f/96f31ac4ff3f4bebb7196c82e8f9845a.jpg, createdBy=2b415520667, createdName=noctis-, createdTime=Wed Jun 16 10:00:22 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973986, encodeId=d4199e398659, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:10:33 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973985, encodeId=715e9e398591, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:09:47 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973978, encodeId=fea19e39789e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e985494754, createdName=ms9000001266443457, createdTime=Wed Jun 16 07:56:47 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 ms3000000367260972

    学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1258027, encodeId=0543125802e0c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 17 22:22:34 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974285, encodeId=70819e428555, content=疫苗接种率防疫的关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Jun 17 08:25:40 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974057, encodeId=91479e4057df, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b255520900, createdName=ms7000001644417250, createdTime=Wed Jun 16 11:45:59 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029601, encodeId=108b1029601a3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 16 10:22:34 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974026, encodeId=63d19e4026f6, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/06f7c5da39ab431d951fe3a04f13726f/96f31ac4ff3f4bebb7196c82e8f9845a.jpg, createdBy=2b415520667, createdName=noctis-, createdTime=Wed Jun 16 10:00:22 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973986, encodeId=d4199e398659, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:10:33 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973985, encodeId=715e9e398591, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89975525961, createdName=ms3000000367260972, createdTime=Wed Jun 16 08:09:47 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973978, encodeId=fea19e39789e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e985494754, createdName=ms9000001266443457, createdTime=Wed Jun 16 07:56:47 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 ms9000001266443457

    学习了

    0

相关资讯

Novavax的新冠疫苗整体有效率达90%,对多种变种病毒同样有效

Novavax新冠疫苗总体有效率约为 90%,初步数据显示它是安全的。

Lancet:英国苏格兰数据显示AZ新冠疫苗似乎不如辉瑞新冠疫苗有效

与 alpha (B.1.1.7) 变体相比,住院人数翻了一番

2021年6月14日全球新冠肺炎疫情及疫苗接种简报:日新增29.3万,贫富国家现疫苗鸿沟逐渐加大,英国疫情出现明显反弹

截至北京时间2021年6月14日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17669万例,新增292,553例,达到176,699,96

2021年6月15日全球新冠肺炎疫情及疫苗接种简报:日新增29.3万,新冠病毒传播速度比全球疫苗分发速度要快,Novavax的新冠疫苗效果**

截至北京时间2021年6月15日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17700万例,新增292,619例,达到177,009,33

Blood:CLL患者接种新冠BNT162b2 mRNA疫苗后的抗体反应

CLL患者对COVID-19的BNT162b2 mRNA疫苗的抗体介导的反应明显受损,而且受CLL疾病活性和治疗情况的影响

BMJ:8个国家超1亿人群数据汇总,探讨新冠疫苗接种后不良事件

不同年龄组和性别的AESIs的观察率存在很大差异,这表明在使用背景率进行安全监测之前,需要进行分层或标准化。

Baidu
map
Baidu
map
Baidu
map